866-945-0263 | enquiries@arrowheadpublishers.com

Press Releases

September 8, 2016

Cara Therapeutics to Present Novel Kappa Opioid Receptor Agonist Research at Upcoming Pain Summit

Cara Therapeutics has recently resumed clinical trials for its novel kappa opioid receptor agonist CR845 in managing acute and chronic pain. 

After the FDA clinical hold on CR845 for postoperative pain was removed in late April 2016, Cara Therapeutics has resumed patient enrollment in several clinical trials. Dr. Joe Stauffer, Chief Medical Officer, Cara Therapeutics, will be presenting the latest post-operative and chronic pain data at the 10th Annual Pain & Migraine Therapeutics Summit. Dr. Stauffer will also be presenting an informative review of the kappa opioid class, and the human abuse liability data of CR845. For more information, visit: http://paintherapeuticsummit.com.

CR845 is a peripherally acting kappa opioid receptor agonist being investigated in managing acute and chronic pain. In Phase 2 trials, CR845 treatment showed significant reductions in both pain and opioid-related side effects. Cara Therapeutics will quickly resume the CLIN3001 adaptive Phase 3 trial of I.V. CR845 for postoperative pain. For the latest information on CR845, visit: http://www.caratherapeutics.com/index.shtml.

The 10th Annual Pain & Migraine Therapeutics Summit is the US’s premier pain conference covering the field of pain research and therapeutics. With various stakeholders in pharmaceutical, biotech, device and medical communities attending, this conference will provide multi-faceted perspectives on the latest pain research. For more information, please download a brochure at: http://www.paintherapeuticsummit.com/brochure.

For more information, please contact:

John Waslif: Managing Director

Arrowhead Publishers

866-945-0263 ext 700

This email address is being protected from spambots. You need JavaScript enabled to view it.


Rachel Donlon: Marketing Associate

Arrowhead Publishers

866-945-0263 ext 701

This email address is being protected from spambots. You need JavaScript enabled to view it.


Contact Us

PO Box 96
Chanhassen, MN 55317 USA

Speaker Opportunities

If you are interested in speaking at one of Arrowhead's conferences or would like to suggest a conference theme for which you have particular expertise, we'd like to hear from you.

Sponsor/Exhibitor Opportunities

Arrowhead sponsorship and exhibitor levels are designed to give your organization the highest level of exposure and opportunity to market products and branding in an environment that is targeted toward facilitating professional networking. We can also build tailor-made packages that will meet your organization's marketing budget and goals. Arrowhead sponsorships are proven to help grow businesses through direct and targeted exposure to industry leaders and decision makers. To gain critical industry exposure via our sponsorship and exhibiting opportunities, please contact us.